SUNPHARMA1,850.00

Sun Pharmaceutical Industries Ltd.

· Pharma & Health
₹ CrorePeersCIPLADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹4.44L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment10,192.310,035.911,114.111,114.1
+ Capital Work-in-Progress1,107.71,234.31,380.71,380.7
+ Goodwill8,599.08,939.49,833.19,833.1
+ Other Intangibles4,420.13,610.911,875.111,875.1
+ Intangibles under Development4,246.25,409.61,671.11,671.1
+ Investments (Equity Method)442.6448.70.00.0
+ Non-current Investments5,998.64,249.03,789.13,789.1
+ Long-term Loans0.92.81.81.8
+ Other Non-current Financial Assets118.0177.066.666.6
Non-current Financial Assets6,117.44,428.83,857.43,857.4
+ Deferred Tax Assets4,103.74,407.64,046.54,046.5
+ Other Non-current Assets2,759.0960.81,116.11,116.1
Total Non-current Assets41,987.939,476.144,894.044,894.0
Current Assets
+ Inventories9,868.310,243.311,492.911,492.9
+ Current Investments8,584.513,656.120,933.520,933.5
+ Trade Receivables11,249.413,046.115,509.715,509.7
+ Cash & Cash Equivalents9,285.710,268.89,770.59,770.5
+ Other Bank Balances1,235.01,062.91,832.61,832.6
+ Short-term Loans65.048.452.752.7
+ Other Current Financial Assets917.21,740.71,403.71,403.7
Current Financial Assets31,336.839,822.949,502.649,502.6
+ Other Current Assets2,228.02,527.92,864.82,864.8
Total Current Assets43,433.152,594.163,860.363,860.3
Total Assets85,462.992,100.61,08,785.21,08,785.2
Equity
+ Equity Share Capital239.9239.9239.9239.9
+ Other Equity / Reserves63,426.871,978.183,330.283,330.2
Equity — Owners of Parent63,666.872,218.083,570.183,570.1
+ Minority Interest3,439.2267.9309.7309.7
Total Equity67,106.072,486.083,879.783,879.7
Liabilities
+ Borrowings — Non-current1.32.531.331.3
+ Other Non-current Financial Liab302.3366.4992.4992.4
Non-current Financial Liabilities303.6368.91,023.71,023.7
+ Provisions — Non-current413.9465.0512.2512.2
+ Deferred Tax Liabilities155.1192.4378.0378.0
+ Other Non-current Liabilities499.9394.0369.6369.6
Non-current Liabilities1,372.51,420.42,283.42,283.4
+ Borrowings — Current2,844.41,867.14,050.44,050.4
+ Trade Payables5,653.36,184.37,333.87,333.8
+ Other Current Financial Liab1,632.42,084.72,756.32,756.3
Current Financial Liabilities10,130.110,136.114,140.414,140.4
+ Provisions — Current5,357.66,155.15,944.15,944.1
+ Current Tax Liabilities411.7733.21,350.01,350.0
+ Other Current Liabilities1,084.51,169.81,187.51,187.5
Current Liabilities16,983.818,194.222,622.022,622.0
Total Liabilities18,356.919,614.624,905.524,905.5
Total Equity & Liabilities85,462.992,100.61,08,785.21,08,785.2
Assets — additional as-filed lines
+ Non-current Assets Held for Sale41.930.430.930.9
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale0.6
Trade Payables — MSME split
+ Dues to Other Creditors — Current6,184.37,333.87,333.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 199%.